Market
First country to approve AI-designed mRNA cancer vaccine by end of 2025?
2
Resolution / Starting Odds
United States • 25%
United Kingdom • 25%
Germany • 25%
Other • 25%
Official announcements from governmental health agencies
Story
Oracle CEO Larry Ellison Announces AI-Designed mRNA Cancer Vaccines in 48 Hours, Highlights Early Detection in White House Project Starship
Jan 21, 2025, 11:04 PM
Larry Ellison, CEO of Oracle, announced at the White House that artificial intelligence (AI) will soon enable the design of personalized mRNA vaccines for cancer treatment within 48 hours. Ellison emphasized the potential of AI in early cancer detection and the development of tailored therapies, stating, "This is the promise of AI." He highlighted the ongoing work to utilize AI for gene sequencing of tumors, which would facilitate the creation of customized vaccines. Ellison's vision reflects a broader commitment to revolutionizing healthcare through technology, aiming to redefine cancer treatment and improve patient outcomes.
View original story
Similar markets
China • 25%
EU • 25%
USA • 25%
Other • 25%
United States • 25%
Other • 25%
Germany • 25%
United Kingdom • 25%
United Kingdom • 25%
Other • 25%
Germany • 25%
United States • 25%
Brazil • 25%
Other • 25%
China • 25%
India • 25%
Other • 25%
Breast Cancer • 25%
Lung Cancer • 25%
Prostate Cancer • 25%
Oracle • 25%
Moderna • 25%
Other • 25%
BioNTech • 25%
Australia • 25%
Canada • 25%
United Kingdom • 25%
United States • 25%
United Kingdom • 25%
United States • 25%
Other • 25%
European Union • 25%
No countries • 25%
6 to 10 countries • 25%
More than 10 countries • 25%
1 to 5 countries • 25%
Texas • 25%
New York • 25%
Other • 25%
California • 25%